卵巢癌診斷市場報告：2030 年趨勢、預測與競爭分析

卵巢癌診斷的趨勢和預測

預計到 2030 年，全球卵巢診斷市場將達到 22.7 億美元，2024 年至 2030 年年複合成長率為 6.9%。該市場的主要促進因素是卵巢癌盛行率的增加、癌症意識的提高以及對改進和增強診斷過程和技術的需求不斷增加。由於癌症診斷中心、醫院實驗室和研究機構市場的商機，全球卵巢癌診斷市場前景看好。

卵巢癌診斷市場洞察

Lucintel 預測診斷影像將在預測期內實現最高成長，並且更加重視癌症的早期檢測和分期。

在這個市場中，由於越來越多的患者湧入醫院進行癌症診斷、消費者意識的提高以及醫療基礎設施投資的增加，醫院實驗室將繼續成為最大的細分市場。

由於卵巢癌發病率不斷上升、老年人口迅速成長以及該地區主要市場參與企業的存在，預計北美在預測期內仍將是最大的地區。

市場規模/估計：以金額的卵巢癌診斷市場規模估計（10 億美元）。

趨勢和預測分析：各個細分市場和地區的市場趨勢（2018-2023）和預測（2024-2030）。

細分分析：按產品類型、診斷類型、癌症類型和金額地區（十億美元）估計卵巢癌診斷市場規模。

區域分析：北美、歐洲、亞太地區以及世界其他地區、中東和非洲的卵巢癌診斷市場細分。

成長機會：依產品類型、診斷類型、癌症類型和卵巢癌診斷市場區域進行成長機會分析。

策略分析：卵巢癌診斷市場的併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

• Q.1. 細分市場中最有前途和高成長的機會是什麼？
• Q.2.哪個細分市場將以更快的速度成長？為什麼？
• Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
• Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
• Q.5. 這個市場的商業風險和競爭威脅是什麼？
• Q.6.這個市場有哪些新趨勢？為什麼？
• Q.7.市場客戶需求有何改變？
• Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
• Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
• Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
• Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球卵巢癌診斷市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球卵巢癌診斷市場趨勢（2018-2023）與預測（2024-2030）
• 全球卵巢癌診斷市場（按產品）
  • 裝置
  • 試劑盒和試劑
• 按診斷類型分類的全球卵巢癌診斷市場
  • 影像
  • 驗血
  • 切片檢查
  • 其他
• 按癌症類型分類的全球卵巢診斷市場
  • 上皮性腫瘤
  • 生殖細胞
  • 間質細胞瘤
• 全球卵巢癌診斷市場（依最終用途）
  • 癌症診斷中心
  • 醫院實驗室
  • 研究機構
  • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

• 全球卵巢診斷市場（按地區）
• 北美卵巢癌診斷市場
• 歐洲卵巢癌診斷市場
• 亞太地區卵巢癌診斷市場
• 其他地區卵巢癌診斷市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球卵巢癌診斷市場成長機會（按產品）
  • 按診斷類型分類的全球卵巢癌診斷市場成長機會
  • 按癌症類型分類的全球卵巢診斷市場成長機會
  • 全球卵巢癌診斷市場成長機會（依最終用途）
  • 全球卵巢癌診斷市場按地區成長機會
• 全球卵巢癌診斷市場新趨勢
• 戰略分析
  • 新產品開發
  • 全球卵巢診斷市場的產能擴張
  • 全球卵巢癌診斷市場的合併、收購與合資企業
  • 認證和許可

第7章 主要企業概況

• F. Hoffmann-La Roche
• Tosoh
• Luminex Corporation
• Quest Diagnostics Incorporated
• Thermo Fisher Scientific
• Ngenebio
• Abbott
• Siemens healthcare
• Myriad genetics
• Bio-rad laboratories

Ovarian Cancer Diagnostics Trends and Forecast

The future of the global ovarian cancer diagnostics market looks promising with opportunities in the cancer diagnostic center, hospital laboratory, and research institute markets. The global ovarian cancer diagnostics market is expected to reach an estimated $2.27 billion by 2030 with a CAGR of 6.9% from 2024 to 2030. The major drivers for this market are growing prevalence of ovarian cancer, increasing awareness towards cancer, and rising demand for improved and enhanced diagnostic processess and techniques.

A more than 150-page report is developed to help in your business decisions.

Ovarian Cancer Diagnostics by Segment

The study includes a forecast for the global ovarian cancer diagnostics by product, diagnosis type, cancer type, end use, and region.

Ovarian Cancer Diagnostics Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Kits and Reagents

Ovarian Cancer Diagnostics Market by Diagnosis Type [Shipment Analysis by Value from 2018 to 2030]:

• Imaging
• Blood Test
• Biopsy
• Others

Ovarian Cancer Diagnostics Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:

• Epithelial Tumor
• Germ Cell
• Stromal Cell Tumor

Ovarian Cancer Diagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Cancer Diagnostic Centers
• Hospital Laboratories
• Research Institutes
• Others

Ovarian Cancer Diagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Ovarian Cancer Diagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ovarian cancer diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ovarian cancer diagnostics companies profiled in this report include-

• F. Hoffmann-La Roche
• Tosoh
• Luminex Corporation
• Quest Diagnostics Incorporated
• Thermo Fisher Scientific
• Ngenebio
• Abbott
• Siemens Healthcare
• Myriad Genetics
• Bio-Rad Laboratories

Ovarian Cancer Diagnostics Market Insights

Lucintel forecasts that imaging is expected to witness highest growth over the forecast period due to the growing emphasis on early cancer detection and staging.

Within this market, hospital laboratories will remain the largest segment due to growing inflow of patient for cancer diagnosis in hospitals, rising consumer awareness, and increasing investments in healthcare infrastructures.

North America will remain the largest region over the forecast period due to increasing icidence of ovarian cancer, surge in elderly population, and presence of leading market players in the region.

Features of the Global Ovarian Cancer Diagnostics Market

Market Size Estimates: Ovarian cancer diagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ovarian cancer diagnostics market size by product, diagnosis type, cancer type, and region in terms of value ($B).

Regional Analysis: Ovarian cancer diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, diagnosis types, cancer types, and regions for the ovarian cancer diagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ovarian cancer diagnostics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the ovarian cancer diagnostics market size?

Answer: The global ovarian cancer diagnostics market is expected to reach an estimated $2.27 billion by 2030.

Q.2 What is the growth forecast for ovarian cancer diagnostics market?

Answer: The global ovarian cancer diagnostics market is expected to grow with a CAGR of 6.9% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the ovarian cancer diagnostics market?

Answer: The major drivers for this market are growing prevalence of ovarian cancer, increasing awareness towards cancer, and rising demand for improved and enhanced diagnostic processess and techniques.

Q4. What are the major segments for ovarian cancer diagnostics market?

Answer: The future of the ovarian cancer diagnostics market looks promising with opportunities in the cancer diagnostic center, hospital laboratory, and research institute markets.

Q5. Who are the key ovarian cancer diagnostics market companies?

Answer: Some of the key ovarian cancer diagnostics companies are as follows:

• F. Hoffmann-La Roche
• Tosoh
• Luminex Corporation
• Quest Diagnostics Incorporated
• Thermo Fisher Scientific
• Ngenebio
• Abbott
• Siemens healthcare
• Myriad genetics
• Bio-rad laboratories

Q6. Which ovarian cancer diagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that imaging is expected to witness highest growth over the forecast period due to the growing emphasis on early cancer detection and staging.

Q7. In ovarian cancer diagnostics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing icidence of ovarian cancer, surge in elderly population, and presence of leading market players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the ovarian cancer diagnostics market by product (instruments and kits & reagents), diagnosis type (imaging, blood test, biopsy, and others), cancer type (epithelial tumor, germ cell, and stromal cell tumor), end use (cancer diagnostic centers, hospital laboratories, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Ovarian Cancer Diagnostics Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Ovarian Cancer Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Ovarian Cancer Diagnostics Market by Product
  • 3.3.1: Instruments
  • 3.3.2: Kits and Reagents
• 3.4: Global Ovarian Cancer Diagnostics Market by Diagnosis Type
  • 3.4.1: Imaging
  • 3.4.2: Blood Test
  • 3.4.3: Biopsy
  • 3.4.4: Others
• 3.5: Global Ovarian Cancer Diagnostics Market by Cancer Type
  • 3.5.1: Epithelial Tumor
  • 3.5.2: Germ Cell
  • 3.5.3: Stromal Cell Tumor
• 3.6: Global Ovarian Cancer Diagnostics Market by End Use
  • 3.6.1: Cancer Diagnostic Centers
  • 3.6.2: Hospital Laboratories
  • 3.6.3: Research Institutes
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Ovarian Cancer Diagnostics Market by Region
• 4.2: North American Ovarian Cancer Diagnostics Market
  • 4.2.2: North American Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
• 4.3: European Ovarian Cancer Diagnostics Market
  • 4.3.1: European Ovarian Cancer Diagnostics Market by Diagnosis Type: Imaging, Blood Test, Biopsy, and Others
  • 4.3.2: European Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
• 4.4: APAC Ovarian Cancer Diagnostics Market
  • 4.4.1: APAC Ovarian Cancer Diagnostics Market by Diagnosis Type: Imaging, Blood Test, Biopsy, and Others
  • 4.4.2: APAC Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
• 4.5: ROW Ovarian Cancer Diagnostics Market
  • 4.5.1: ROW Ovarian Cancer Diagnostics Market by Diagnosis Type: Imaging, Blood Test, Biopsy, and Others
  • 4.5.2: ROW Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Product
  • 6.1.2: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Diagnosis Type
  • 6.1.3: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Cancer Type
  • 6.1.4: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by End Use
  • 6.1.5: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Region
• 6.2: Emerging Trends in the Global Ovarian Cancer Diagnostics Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Ovarian Cancer Diagnostics Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ovarian Cancer Diagnostics Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F. Hoffmann-La Roche
• 7.2: Tosoh
• 7.3: Luminex Corporation
• 7.4: Quest Diagnostics Incorporated
• 7.5: Thermo Fisher Scientific
• 7.6: Ngenebio
• 7.7: Abbott
• 7.8: Siemens healthcare
• 7.9: Myriad genetics
• 7.10: Bio-rad laboratories